Research News

Duke Anesthesiology Ranks Among Top Three in NIH Funding

The Blue Ridge Institute for Medical Research ranks Duke Anesthesiology the #3 anesthesiology clinical science department in the country for National Institutes of Health funding, securing our reputation as one of the premier research institutions in anesthesiology.

Dr. Serbanescu Earns a Strong Start Award

Congratulations to Duke Anesthesiology’s Mara Serbanescu, MD, on being among the six Duke University School of Medicine faculty members selected to receive a Physician-Scientist Strong Start Award, designed to support outstanding lab-based clinician-scientists.

Probiotics Reduce COVID Symptoms and Delay Disease Among Unvaccinated

A new study led by Duke Health researchers, including Duke Anesthesiology's Dr. Paul Wischmeyer (co-lead author), and published in Clinical Nutrition suggests that probiotics could be a relatively simple and inexpensive approach to treating people after a COVID exposure.

New Test Predicts Risk of Cognitive Dysfunction in Older Surgery Patients

New research led by Duke Anesthesiology’s Dr. Leah Acker and published in the British Journal of Anaesthesia reveals that a simple preoperative electroencephalogram measurement detects a signal of cognitive vulnerability when patients are asked to close, then open their eyes.

That’s a Wrap! Highlights from ASA 2023

It was another successful American Society of Anesthesiologists (ASA) meeting for Duke Anesthesiology! View the photo gallery and read the full recap from San Francisco!

Blood-Brain Barrier is More Permeable in Patients with Delirium after Surgery

New research led by Duke Anesthesiology’s Dr. Michael Devinney and published in the Annals of Neurology reveals that patients who develop postoperative delirium have greater increases in permeability in the blood-brain barrier, pointing the way toward potential new therapies to prevent this common postoperative complication.

Dr. Ji Awarded NIH Grant to Study Checkpoint Inhibitors for Pain Control

Congratulations to Ru-Rong Ji, PhD, on receiving a three year $2,569,851 grant from the National Institutes of Health for research aimed at providing novel insights into distinct actions of checkpoint pathway activators and inhibitors for the management of different types of pain.

Dr. Nackley Awarded NIH Grant for Innovative Pain Therapy Research

Congratulations to Andrea Nackley, PhD, on receiving a two-year $1,846,202 R61 grant to develop novel Adrb3 antagonists for the treatment of chronic primary pain conditions as part of the NIH’s Helping to End Addiction Long-term (HEAL) Initiative.